Diploma (LON:DPLM) Stock Passes Above Two Hundred Day Moving Average – Here’s Why

Diploma PLC (LON:DPLM) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 4,870.30 ($65.07) and traded as high as GBX 5,500 ($73.48). Diploma shares last traded at GBX 5,460 ($72.95), with a volume of 1,598,339 shares changing hands.

Wall Street Analysts Forecast Growth

DPLM has been the subject of several research analyst reports. Berenberg Bank boosted their price objective on Diploma from GBX 5,750 to GBX 6,350 and gave the company a “buy” rating in a research report on Wednesday, September 10th. JPMorgan Chase & Co. restated a “neutral” rating and issued a GBX 4,440 price target on shares of Diploma in a research note on Wednesday, August 6th. Royal Bank Of Canada raised Diploma to an “outperform” rating and raised their price objective for the company from GBX 4,500 to GBX 6,000 in a research report on Friday, October 3rd. Jefferies Financial Group lifted their price target on Diploma from GBX 4,500 to GBX 5,200 and gave the stock a “hold” rating in a report on Thursday, September 11th. Finally, Shore Capital reissued a “hold” rating and set a GBX 5,100 price target on shares of Diploma in a report on Thursday, July 17th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 5,365.

Diploma Trading Down 0.2%

The business has a 50 day moving average of GBX 5,383.55 and a two-hundred day moving average of GBX 4,870.30. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The firm has a market capitalization of £7.30 billion, a price-to-earnings ratio of 43.85, a P/E/G ratio of 2.82 and a beta of 0.75.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.